Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Yangzheng Xiaoji for Niraparib-induced Nausea in Advanced Ovarian Cancer
NCT05641506Phase 2Unknown
- Sponsor
- Sichuan Cancer Hospital
- Start
- Dec 2022
- Primary completion
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of yangzheng xiaoji capsule in nausea ((none)), sponsored by Sichuan Cancer Hospital. Status: unknown.
02
Drugs
yangzheng xiaoji capsule
03
Conditions
nausea ((none))
Beyond the preview
Go deeper on NCT05641506.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05641506.